Activation of CCR2 signaling prompts TAMs to secrete another chemokine, CCL3, leading to enhanced TAMs–tumor cell interaction and prolonged retention of TAMs in the metastases sites, which promotes extravasation of breast cancer cells (165, 166). Here, CCL3 is linked to neoplasm.